查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1963632

迷走神经刺激市场：全球产业分析、规模、份额、成长、趋势与预测（2025-2032）

Vagus Nerve Stimulation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
出版日期: | 出版商: Persistence Market Research | 英文 200 Pages | 商品交期: 2-5个工作天内

价格
简介目录

主要发现：

  • 迷走神经刺激市场规模（2025年预测）：5.423亿美元
  • 预计市场规模（2032年）：10.134亿美元
  • 全球市场成长率（2025年至2032年复合年增长率）：9.3%

迷走神经刺激市场研究范围：

迷走神经刺激（VNS）是一种神经调控疗法，透过向迷走神经传递电脉衝来调节神经和生理功能。 VNS 设备用于治疗癫痫、忧郁症和偏头痛等疾病，尤其适用于对传统治疗方法反应不佳的患者。迷走神经刺激市场涵盖了医院和专科神经科中心使用的植入式和非侵入式设备。市场成长的驱动因素包括神经系统疾病盛行率的上升、治疗适应症的扩大以及神经调控设备的技术进步。

市场成长驱动因素：

全球迷走神经刺激市场受多种关键因素驱动，包括癫痫、忧郁症等神经系统疾病和慢性疾病的日益普遍。神经调控疗法作为药物治疗的替代方案，其应用范围不断扩大，也推动了市场成长。技术进步，尤其是非侵入性刺激设备的进步，提高了患者的舒适度和治疗的可及性。此外，不断增加的研发投入和支持性的管理方案，正在加速创新迷走神经刺激解决方案的开发和应用。

市场限制：

儘管迷走神经刺激市场前景广阔，但仍面临许多挑战，例如设备高成本以及部分地区认知度有限。植入式设备需要手术，这可能会阻碍部分患者的接受度。此外，对专业培训和临床经验的需求也可能限制其广泛应用。安全性、报销政策和监管要求等方面的担忧也可能成为市场扩张的障碍。

市场机会：

由于技术创新和临床应用的不断拓展，迷走神经刺激市场展现出巨大的成长潜力。非侵入式和穿戴式刺激器的研发为寻求手术替代方案的患者提供了新的治疗选择。针对中风復健和发炎性疾病等新治疗领域的研究不断深入，可望进一步扩大迷走神经刺激疗法的应用范围。策略合作、资金筹措倡议对神经调控研究投入的持续成长，都将有助于推动市场的长期发展。

本报告解答的关键问题：

  • 推动全球迷走神经刺激市场成长的关键因素是什么？
  • 哪些设备类型和应用正在推动各种医疗保健机构的采用？
  • 科技进步如何改变迷走神经刺激市场的竞争格局？
  • 哪些主要企业参与者？它们正在采取哪些策略来维持其市场地位？
  • 全球迷走神经刺激市场有哪些新兴趋势与未来前景？

目录

第一章执行摘要

第二章 市场概览

  • 市场范围和定义
  • 市场动态
    • 司机
    • 抑制因素
    • 机会
    • 主要趋势
  • 宏观经济因素
  • 新冠疫情影响分析
  • 预测因子－相关性和影响

第三章 加值见解

  • 产品导入分析
  • 监管状态
  • 价值链分析
  • 重大交易和合併
  • PESTLE分析
  • 波特五力分析

第四章 定价分析，2024年

  • 主要亮点
  • 影响产品价格的关键因素
  • 产品价格分析
  • 区域价格和产品偏好

第五章 全球迷走神经刺激市场展望

  • 主要亮点
    • 市场规模（单位）预测
    • 市场规模和年成长率
    • 绝对商机
  • 市场规模分析与预测
    • 2019年至2024年市场规模表现分析
    • 市场规模分析及预测（2025-2032年）
  • 全球迷走神经刺激市场展望：产品
    • 引言/主要发现
    • 2019-2024年按产品分類的市场规模、表现及销售量（单位）分析
    • 市场规模及销售量（单位）分析及预测（依产品划分），2025-2032 年
      • 植入式迷走神经刺激器
      • 外部非侵入式迷走神经刺激装置
    • 产品市场吸引力分析
  • 全球迷走神经刺激（VNS）市场依应用领域展望
    • 引言/主要发现
    • 按应用领域分類的市场规模绩效分析（2019-2024 年）
    • 按应用领域分類的市场规模分析与预测（2025-2032年）
      • 癫痫
      • 忧郁症
      • 偏头痛
      • 其他的
    • 按应用领域进行市场吸引力分析
  • 全球迷走神经刺激市场展望：终端用户
    • 引言/主要发现
    • 按最终用户分類的市场规模绩效分析，2019-2024 年
    • 依最终用户分類的市场规模分析及预测（2025-2032 年）
      • 医院
      • 专科诊所
      • 门诊手术中心
      • 学术和研究机构
      • 其他的
    • 市场吸引力分析：最终用户

6. 全球迷走神经刺激市场区域展望

  • 主要亮点
  • 2019年至2024年各地区市场规模表现分析
  • 市场规模分析及预测（依地区划分，2025-2032年）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 按地区分類的市场吸引力分析

7. 北美迷走神经刺激市场展望

8. 欧洲迷走神经刺激市场展望

第九章 东亚迷走神经刺激市场展望

10. 南亚与大洋洲迷走神经刺激市场展望

11. 拉丁美洲迷走神经刺激市场展望

12. 中东与非洲迷走神经刺激市场展望

第十三章 竞争格局

  • 2024年市占率分析
  • 市场结构
    • 市场竞争强度分布图
    • 竞争对手仪錶板
  • 公司简介（详情 - 概述、财务状况、策略、近期发展）
    • Soterix Medical Inc.
    • LivaNova PLC
    • SetPoint Medical
    • Vagutism
    • tVNS Technologies GmbH
    • electroCore, Inc.
    • Adriakaim, Inc.
    • MicroTransponder Inc.
    • Parasym, Ltd.
    • Pulsetto
    • Teliatry, Inc.
    • biolitec（R）Holding GmbH &Co KG
    • AURIMOD GMBH
    • Evren Technologies, Inc.
    • NeurGear
    • Hoolest
    • Neuvana
    • BioSelf Technology Ltd.

第十四章附录

简介目录
Product Code: PMRREP34750

Persistence Market Research has recently released a comprehensive report on the worldwide market for vagus nerve stimulation. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global vagus nerve stimulation market from 2025 to 2032.

Key Insights:

  • Vagus Nerve Stimulation Market Size (2025E): USD 542.3 Million
  • Projected Market Value (2032F): USD 1,013.4 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 9.3%

Vagus Nerve Stimulation Market - Report Scope:

Vagus nerve stimulation (VNS) is a neuromodulation therapy that involves delivering electrical impulses to the vagus nerve to regulate neurological and physiological functions. VNS devices are used in the treatment of conditions such as epilepsy, depression, and migraine, particularly in patients who do not respond adequately to conventional therapies. The vagus nerve stimulation market includes implantable and non-invasive devices used in hospitals and specialized neurology centers. Market growth is driven by increasing prevalence of neurological disorders, expanding therapeutic applications, and technological advancements in neuromodulation devices.

Market Growth Drivers:

The global vagus nerve stimulation market is propelled by several key factors, including the rising prevalence of neurological and chronic disorders such as epilepsy and depression. Increasing adoption of neuromodulation therapies as alternatives to pharmaceutical treatments has supported market growth. Technological advancements, particularly in non-invasive stimulation devices, have improved patient comfort and accessibility. In addition, growing research investments and supportive regulatory initiatives have accelerated the development and adoption of innovative vagus nerve stimulation solutions.

Market Restraints:

Despite promising growth prospects, the vagus nerve stimulation market faces challenges related to high device costs and limited awareness in certain regions. Implantable devices require surgical procedures, which may discourage adoption among some patients. In addition, the need for specialized training and clinical expertise can limit widespread use. Concerns regarding safety, reimbursement policies, and regulatory requirements may also create barriers to market expansion.

Market Opportunities:

The vagus nerve stimulation market presents significant growth opportunities driven by technological innovation and expanding clinical applications. The development of non-invasive and wearable stimulation devices offers new treatment options for patients seeking alternatives to surgery. Expanding research into new therapeutic areas, such as stroke rehabilitation and inflammatory diseases, is expected to broaden the scope of VNS therapy. Strategic collaborations, funding initiatives, and increased investment in neuromodulation research are likely to support long-term market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the vagus nerve stimulation market globally?
  • Which device types and applications are driving adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the vagus nerve stimulation market?
  • Who are the key players contributing to the vagus nerve stimulation market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global vagus nerve stimulation market?

Competitive Intelligence and Business Strategy:

Leading players in the global vagus nerve stimulation market focus on innovation, clinical research, and strategic partnerships to strengthen their market position. Companies invest in advanced neuromodulation technologies, including implantable and external stimulation devices, to improve therapeutic outcomes. Collaborations with research institutions and healthcare providers help expand clinical applications and accelerate product adoption. Continuous product development and regulatory approvals are expected to enhance competitiveness in the rapidly evolving neuromodulation landscape.

Key Companies Profiled:

  • LivaNova PLC
  • electroCore, Inc.
  • MicroTransponder Inc.
  • tVNS Technologies GmbH
  • SetPoint Medical
  • Parasym Ltd.
  • Soterix Medical Inc.
  • AURIMOD GmbH
  • Neuvana
  • Pulsetto
  • BioSelf Technology Ltd.

Vagus Nerve Stimulation Market Research Segmentation:

By Product:

  • Implantable VNS Devices
  • External Non-invasive VNS Devices

By Application:

  • Epilepsy
  • Depression
  • Migraine
  • Stroke Rehabilitation
  • Others

By End-User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Vagus Nerve Stimulation Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Vagus Nerve Stimulation Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019 - 2024
    • 5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 5.3. Global Vagus Nerve Stimulation Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019 - 2024
    • 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Implantable VNS Device
      • 5.3.3.2. External Non-invasive VNS Device
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Vagus Nerve Stimulation Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 - 2024
    • 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 5.4.3.1. Epilepsy
      • 5.4.3.2. Depression
      • 5.4.3.3. Migraine
      • 5.4.3.4. Others
    • 5.4.4. Market Attractiveness Analysis: Application
  • 5.5. Global Vagus Nerve Stimulation Market Outlook: End User
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019 - 2024
    • 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Specialty Clinics
      • 5.5.3.3. Ambulatory Surgical Centers
      • 5.5.3.4. Academic & Research Institutes
      • 5.5.3.5. Others
    • 5.5.4. Market Attractiveness Analysis: End User

6. Global Vagus Nerve Stimulation Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
  • 6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Vagus Nerve Stimulation Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Implantable VNS Device
    • 7.4.2. External Non-invasive VNS Device
  • 7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Epilepsy
    • 7.5.2. Depression
    • 7.5.3. Migraine
    • 7.5.4. Others
  • 7.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Specialty Clinics
    • 7.6.3. Ambulatory Surgical Centers
    • 7.6.4. Academic & Research Institutes
    • 7.6.5. Others
  • 7.7. Market Attractiveness Analysis

8. Europe Vagus Nerve Stimulation Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Implantable VNS Device
    • 8.4.2. External Non-invasive VNS Device
  • 8.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Epilepsy
    • 8.5.2. Depression
    • 8.5.3. Migraine
    • 8.5.4. Others
  • 8.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Specialty Clinics
    • 8.6.3. Ambulatory Surgical Centers
    • 8.6.4. Academic & Research Institutes
    • 8.6.5. Others
  • 8.7. Market Attractiveness Analysis

9. East Asia Vagus Nerve Stimulation Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Implantable VNS Device
    • 9.4.2. External Non-invasive VNS Device
  • 9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Epilepsy
    • 9.5.2. Depression
    • 9.5.3. Migraine
    • 9.5.4. Others
  • 9.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Specialty Clinics
    • 9.6.3. Ambulatory Surgical Centers
    • 9.6.4. Academic & Research Institutes
    • 9.6.5. Others
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Vagus Nerve Stimulation Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Implantable VNS Device
    • 10.4.2. External Non-invasive VNS Device
  • 10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Epilepsy
    • 10.5.2. Depression
    • 10.5.3. Migraine
    • 10.5.4. Others
  • 10.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Specialty Clinics
    • 10.6.3. Ambulatory Surgical Centers
    • 10.6.4. Academic & Research Institutes
    • 10.6.5. Others
  • 10.7. Market Attractiveness Analysis

11. Latin America Vagus Nerve Stimulation Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Implantable VNS Device
    • 11.4.2. External Non-invasive VNS Device
  • 11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Epilepsy
    • 11.5.2. Depression
    • 11.5.3. Migraine
    • 11.5.4. Others
  • 11.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Specialty Clinics
    • 11.6.3. Ambulatory Surgical Centers
    • 11.6.4. Academic & Research Institutes
    • 11.6.5. Others
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Vagus Nerve Stimulation Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By End User
  • 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Implantable VNS Device
    • 12.4.2. External Non-invasive VNS Device
  • 12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 12.5.1. Epilepsy
    • 12.5.2. Depression
    • 12.5.3. Migraine
    • 12.5.4. Others
  • 12.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Specialty Clinics
    • 12.6.3. Ambulatory Surgical Centers
    • 12.6.4. Academic & Research Institutes
    • 12.6.5. Others
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Soterix Medical Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. LivaNova PLC
    • 13.3.3. SetPoint Medical
    • 13.3.4. Vagutism
    • 13.3.5. tVNS Technologies GmbH
    • 13.3.6. electroCore, Inc.
    • 13.3.7. Adriakaim, Inc.
    • 13.3.8. MicroTransponder Inc.
    • 13.3.9. Parasym, Ltd.
    • 13.3.10. Pulsetto
    • 13.3.11. Teliatry, Inc.
    • 13.3.12. biolitec(R) Holding GmbH & Co KG
    • 13.3.13. AURIMOD GMBH
    • 13.3.14. Evren Technologies, Inc.
    • 13.3.15. NeurGear
    • 13.3.16. Hoolest
    • 13.3.17. Neuvana
    • 13.3.18. BioSelf Technology Ltd.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations